about
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceCannabinoids and the gut: new developments and emerging conceptsBeneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel diseaseThe role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in ratsPotent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusaThe marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cellsCannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammationPharmacological effects of Cimicifuga racemosa.Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting.Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies.Interactions between herbal medicines and prescribed drugs: an updated systematic review.St John's wort: Prozac from the plant kingdom.Cannabis and cannabinoid receptors.Interactions between herbs and conventional drugs: overview of the clinical data.Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.Garlic (Allium sativum L.): adverse effects and drug interactions in humans.The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.Unique pathway for anandamide synthesis and liver regenerationNon-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.The gastrointestinal pharmacology of cannabinoids: an update.Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects.The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat dietThe cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitisInhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.Anandamide-derived prostamide F2α negatively regulates adipogenesisDysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets.Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide.Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cellsIncreased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance.A new acetophenone derivative from flowers of Helichrysum italicum (Roth) Don ssp. italicum.The chemopreventive action of bromelain, from pineapple stem (Ananas comosus L.), on colon carcinogenesis is related to antiproliferative and proapoptotic effects.Induction of nitric oxide synthase expression by Withania somnifera in macrophages.Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells.
P50
Q28258759-393B8A58-D548-440B-87D5-8805A2FD2A28Q28271862-EDC2643D-77BA-4CEB-ACAB-8F8D2D6A9EA9Q28285648-C02CA407-DE48-4F0A-AB2D-0BD3FFA4E247Q28378072-86273AC7-F3E5-42CC-9C01-5B293AF08CECQ28478207-517DC118-CDF7-4405-B979-A1E09A163543Q28575370-24571171-8475-454E-BE30-E7043AB96F7DQ28583653-93027602-41A0-47A5-86C4-CD6893EF7401Q31148831-6FFEDE37-0854-4D26-931C-D756EE08EE69Q33213447-A98C54DF-28DF-4686-8A54-BC11D99850F1Q33215661-C0244FB7-0D5A-44D3-9E16-24B5A9AA15F5Q33498604-C6958B04-3253-4BD5-B4AE-BBD7E91C293AQ33950220-0B3DCDEC-189C-4033-BF43-2CB47EE98F2DQ33994007-5130A287-DF1F-4C0D-8006-74AE410B1A5CQ34124444-C0065526-42A8-40B8-A0B0-FD4AB1A53122Q34441093-F3CFBF1E-CE95-42B7-A71D-DD390B38CC2EQ34571380-997DD811-6B30-4D90-B035-A1D698C43FE4Q34635002-FFF8BF9D-2E81-447F-8611-5054A1814CF5Q34698908-211484D4-78DC-4549-ACE9-915FCA48A077Q34700338-04605146-29C4-4A02-A774-A2ADA4773075Q34795735-F6C7C6C7-5D03-420E-8196-1F0F174A5EF5Q34835434-7677314C-4F18-4B99-888B-D9E4E900818CQ35001117-7CD45A67-91D0-4DFC-AEA1-006204E0E8B2Q35009679-A07C7B48-819B-4B20-A11D-66938FB11642Q35938724-037BBC49-DD91-4C7B-8185-6E850213D1CAQ36025421-C76B3E8A-752F-446C-A8B7-5D3D44931AA9Q36510027-58A6CF48-40CC-4B69-ADE8-195BCB81246BQ36784020-EC31E682-2F5B-439A-95B6-EB5A6C8FCE08Q36977483-729D090A-81B2-4F41-AE19-2E6653C2D906Q37095444-EAC4A1C1-8B2A-432A-89F3-2F58180BED9CQ37111181-011ADFB9-26F9-40D3-9A67-9A18640117DAQ37132540-CD3E236F-F69B-4DD9-A9E3-9FFF308C281DQ37143573-66DDE001-547E-4950-A17D-1316ABA0AF91Q37295725-F963E774-AC12-4F1B-B067-70D2DDC23E7AQ37371891-0FB2B242-1D2C-454F-AC8C-5E5BAC597D68Q37376946-13053E1E-97B2-44E0-AFD3-6BD76F5B03CCQ37414549-9D9BBC8E-4823-4879-B2A8-81BB9B1F93C7Q38950325-8A6C5726-2B92-44B7-860A-E43926FA1544Q39079359-3A3F33F3-EE63-4B2E-A688-E7819979AA64Q40674828-CB056916-A805-4745-A5D4-D02594B22662Q40783943-91267171-0B51-42AB-8499-E0CC14C0141D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Angelo A. Izzo
@ast
Angelo A. Izzo
@en
Angelo A. Izzo
@es
Angelo A. Izzo
@nl
type
label
Angelo A. Izzo
@ast
Angelo A. Izzo
@en
Angelo A. Izzo
@es
Angelo A. Izzo
@nl
prefLabel
Angelo A. Izzo
@ast
Angelo A. Izzo
@en
Angelo A. Izzo
@es
Angelo A. Izzo
@nl
P106
P1153
55382764100
P21
P31
P496
0000-0002-8557-2133